Exco InTouch Unveils New Website and Program for DIA 2013 49th Annual Meeting
Exco InTouch is sending a mix of US and European delegates to DIA, with a strong emphasis on patient-centricity. On booth number 2010 the team will be showcasing its unique mDNA® technology, which increases efficiencies in data management by allowing a truly device independent approach to clinical trials and mHealth programs.
On Thursday 27 June, Director of Clinical Excellence, Judith Teall will give a presentation during the Emerging Electronic Tools in Cardiovascular Outcomes Studies, titled: “Mobile Patient Engagement in CV Outcomes - a two-way process”.
Meanwhile, on Tuesday 25 June Dr Chris Watson, Product Manager at Exco InTouch, will be presenting a poster entitled: “The use of compliant text messaging to increase patient engagement in a study comparing oral contraceptive symptoms”.
Exco InTouch will also unveil its brand new website at DIA, which is designed to be both informative and educational. Featuring a range of infographics, facts and figures about patient engagement and data capture during clinical and late phase trials and mHealth programs, the new website
Ian Jennings, Chief Commercial Officer at Exco InTouch, said: “This is our 6th time at DIA, the flagship event for our industry, and it’s the perfect way to introduce delegates to the work of Exco InTouch. As well as introducing our new website to visitors at Booth 2010, we’ll be demonstrating the versatility of our mDNA® technology and how it can offer secure global mobile services in even the most complex and ever-changing landscapes. Coupled with Judith’s presentation and Chris’s poster, we will give visitors a thorough insight into how our patient engagement and data capture solutions can improve health outcomes.”
The DIA 2013 49th Annual Meeting is the largest multidisciplinary event that brings together a community of professionals at all levels and across all disciplines in the discovery, development, and life cycle management of medical products.
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Related Articles
- NIMBLE Trial Reveals New Insights on Complement Inhibition in gMG
September 15th 2025
- Q&A: Strategies for Successful Global Clinical Trial Delivery
September 12th 2025